Noa Markovits

514 total citations
21 papers, 370 citations indexed

About

Noa Markovits is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Noa Markovits has authored 21 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Noa Markovits's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Eosinophilic Disorders and Syndromes (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Noa Markovits is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Eosinophilic Disorders and Syndromes (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Noa Markovits collaborates with scholars based in Israel, Belgium and China. Noa Markovits's co-authors include Ronen Loebstein, Hillel Halkin, Daniel Kurnik, Ami Ben Amotz, Yishai Levy, Ilan Bank, Amitai Ziv, Ari Shamiss, Jacob Lavee and Ilan Matok and has published in prestigious journals such as Scientific Reports, American Journal of Transplantation and Thrombosis and Haemostasis.

In The Last Decade

Noa Markovits

21 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noa Markovits Israel 11 98 67 51 46 41 21 370
Jean Sanderson United Kingdom 9 70 0.7× 42 0.6× 17 0.3× 62 1.3× 16 0.4× 13 584
Nooshin Dalili Iran 11 56 0.6× 73 1.1× 51 1.0× 53 1.2× 6 0.1× 35 429
Cindy George South Africa 12 26 0.3× 21 0.3× 32 0.6× 61 1.3× 17 0.4× 30 522
Vesna Bačić Vrca Croatia 10 87 0.9× 52 0.8× 116 2.3× 29 0.6× 7 0.2× 27 464
Janelle F. Ruisinger United States 14 290 3.0× 50 0.7× 22 0.4× 42 0.9× 7 0.2× 32 595
Adewale Victor Aderemi United Kingdom 6 36 0.4× 40 0.6× 84 1.6× 111 2.4× 15 0.4× 10 484
Emilie Kalbacher France 11 63 0.6× 26 0.4× 27 0.5× 34 0.7× 6 0.1× 20 445
Cecilia Jimeno Philippines 12 43 0.4× 24 0.4× 15 0.3× 35 0.8× 9 0.2× 75 621
Virtudes Álvarez Spain 16 127 1.3× 21 0.3× 34 0.7× 32 0.7× 8 0.2× 30 859
Molouk Hadjibabaie Iran 11 34 0.3× 19 0.3× 20 0.4× 26 0.6× 15 0.4× 32 414

Countries citing papers authored by Noa Markovits

Since Specialization
Citations

This map shows the geographic impact of Noa Markovits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Markovits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Markovits more than expected).

Fields of papers citing papers by Noa Markovits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noa Markovits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Markovits. The network helps show where Noa Markovits may publish in the future.

Co-authorship network of co-authors of Noa Markovits

This figure shows the co-authorship network connecting the top 25 collaborators of Noa Markovits. A scholar is included among the top collaborators of Noa Markovits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noa Markovits. Noa Markovits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markovits, Noa, et al.. (2022). Effects of imatinib on glycemic and lipid profiles: a retrospective cohort study. Leukemia & lymphoma. 63(9). 2224–2232. 6 indexed citations
2.
Berlin, Maya, et al.. (2021). Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study. British Journal of Clinical Pharmacology. 87(10). 3910–3915. 4 indexed citations
3.
Markovits, Noa, et al.. (2021). Oxaliplatin immune‐mediated thrombocytopenia: Is there a role for premedication or desensitization?. British Journal of Clinical Pharmacology. 88(2). 842–845. 1 indexed citations
4.
Markovits, Noa, et al.. (2020). Is Pyroglutamic Acid a Prognostic Factor Among Patients with Suspected Infection? A Prospective Cohort Study. Scientific Reports. 10(1). 10128–10128. 7 indexed citations
5.
Markovits, Noa, et al.. (2020). Concomitant oral potassium chloride and anticholinergic therapy is associated with upper gastrointestinal bleeding: A cohort study. British Journal of Clinical Pharmacology. 87(4). 2064–2069. 1 indexed citations
6.
Mayan, Haim, et al.. (2019). Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study. Scientific Reports. 9(1). 3554–3554. 13 indexed citations
7.
Klempfner, Robert, Noa Markovits, Hillel Halkin, et al.. (2019). Clinically significant incidental QTc prolongation is subject to within‐individual variability. Annals of Noninvasive Electrocardiology. 25(2). e12699–e12699. 11 indexed citations
8.
Markovits, Noa, Havatzelet Yarden‐Bilavsky, Eugenia Raichlin, et al.. (2018). High tacrolimus trough level variability is associated with rejections after heart transplant. American Journal of Transplantation. 18(10). 2571–2578. 45 indexed citations
9.
Ben‐Horin, Shomron, Gert Van Assche, Yehuda Chowers, et al.. (2018). Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies. Journal of Crohn s and Colitis. 12(12). 1410–1417. 6 indexed citations
10.
Pasternak, Yehonatan, et al.. (2018). Voriconazole‐induced QTc prolongation in a paediatric population. Acta Paediatrica. 108(6). 1128–1132. 9 indexed citations
11.
Loebstein, Ronen, et al.. (2017). Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors. European Journal of Clinical Pharmacology. 73(9). 1181–1185. 19 indexed citations
12.
Kurnik, Daniel, Ilan Matok, Hillel Halkin, et al.. (2017). Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients. International Journal of Medical Informatics. 107. 70–75. 46 indexed citations
13.
Markovits, Noa, Ronen Loebstein, & Ilan Bank. (2017). Immune-mediated syndromes following intravenous bisphosphonate therapy. Inflammopharmacology. 25(6). 665–671. 6 indexed citations
14.
Markovits, Noa, et al.. (2015). Database evaluation of the association between serum magnesium levels and the risk of atrial fibrillation in the community. International Journal of Cardiology. 205. 142–146. 21 indexed citations
15.
Kurnik, Daniel, Noa Markovits, Amitai Ziv, et al.. (2014). Implementation of a clinical decision support system for computerized drug prescription entries in a large tertiary care hospital.. PubMed. 16(5). 289–94. 17 indexed citations
16.
Markovits, Noa, et al.. (2014). The association of proton pump inhibitors and hypomagnesemia in the community setting. The Journal of Clinical Pharmacology. 54(8). 889–895. 58 indexed citations
17.
Markovits, Noa, Daniel Kurnik, Hillel Halkin, et al.. (2013). "Body packers" in Israel: a case series.. PubMed. 15(10). 639–45. 7 indexed citations
18.
Lubetsky, Aharon, Noa Markovits, Chun Li, et al.. (2012). Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction. Thrombosis and Haemostasis. 108(10). 781–788. 16 indexed citations
19.
Markovits, Noa, et al.. (2009). Vγ9+ γδ T cells in systemic sclerosis patients are numerically and functionally preserved and induce fibroblast apoptosis. Immunobiology. 215(5). 380–394. 18 indexed citations
20.
Markovits, Noa, Ami Ben Amotz, & Yishai Levy. (2009). The effect of tomato-derived lycopene on low carotenoids and enhanced systemic inflammation and oxidation in severe obesity.. PubMed. 11(10). 598–601. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Sanderson Breakdown of academic impact, for papers by Nooshin Dalili Breakdown of academic impact, for papers by Cindy George Breakdown of academic impact, for papers by Vesna Bačić Vrca Breakdown of academic impact, for papers by Janelle F. Ruisinger Breakdown of academic impact, for papers by Adewale Victor Aderemi Breakdown of academic impact, for papers by Emilie Kalbacher Breakdown of academic impact, for papers by Cecilia Jimeno Breakdown of academic impact, for papers by Virtudes Álvarez Breakdown of academic impact, for papers by Molouk Hadjibabaie
Rankless by CCL
2026